ClinicalTrials.govpublic full text
Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor
acs - acute coronary syndrome, ticagrelor, microbiota, platelet aggregation, myocardial infarction (mi), blood platelets
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 148797
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.